The production of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, requires a complex complicated chemical process. Early routes focused on protein section coupling, utilizing solid-phase production methodologies to build the long amino acid sequence. Subsequent study has explored different approaches, including enzymatic